Scilex Holding Co (NASDAQ: SCLX)

$8.50 -0.20 (-2.30%)
As of Jun 12, 2026 04:00 PM
Sector: Healthcare Industry: Drug Manufacturers - General CIK: 0001820190
Market Cap 58.57 Mn
P/E -0.21
P/S 1.73
Div. Yield 0.00
Total Debt (Qtr) 80.78 Mn
Revenue Growth (1y) (Qtr) 72.00
Add ratio to table...

About

Scilex Holding Co is an innovative revenue generating company focused on acquiring developing and commercializing non opioid pain management products for the treatment of acute and chronic pain. The company markets three FDA approved products ZTlido for postherpetic neuralgia ELYXYB for acute migraine and GLOPERBA for gout prophylaxis. It also has a pipeline of product candidates including SEMDEXA for sciatica SP-103 for acute pain and SP-104 for fibromyalgia. Revenue is generated primarily from sales of its approved products ZTlido ELYXYB and...

Read more

Peer comparison

Companies in the Drug Manufacturers - General
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 GSK GSK plc 96,436,181.12 Bn 12.27 Mn 2.19 Mn -18.89 Bn
2 LLY ELI LILLY & Co 1,017.30 Bn 0.00 Mn 0.00 Mn 43.37 Bn
3 JNJ Johnson & Johnson 579.61 Bn 0.00 Mn 0.00 Mn 54.99 Bn
4 ABBV AbbVie Inc. 402.30 Bn 0.00 Mn 0.00 Mn 64.53 Bn
5 MRK Merck & Co., Inc. 294.24 Bn 0.00 Mn 0.00 Mn 49.12 Bn
6 AMGN Amgen Inc 191.82 Bn 0.00 Mn 0.00 Mn 57.32 Bn
7 GILD Gilead Sciences, Inc. 155.93 Bn 0.00 Mn 0.00 Mn 22.17 Bn
8 PFE Pfizer Inc 149.05 Bn 0.00 Mn 0.00 Mn 64.46 Bn